A recent study examines whether an interactive educational program can improve psychosocial outcomes for adolescents with osteosarcoma.

Subsequent decreasing rates of OS and PFS point to the challenge of long-term CAR T-Cell efficacy and durability of treatment.

Significant improvements seen in overall and disease-free survival, and reduction seen in all-cause, cancer-specific mortality.

In this study, researchers aimed to validate the diagnostic accuracy of urogenital cytology for endometrial cancer detection in postmenopausal women.

Investigators developed a genomic score to assess potential survival benefits in patients with neuroendocrine neoplasms treated with immunotherapy.

Researchers evaluated the complex social and personal factors driving fear of cancer recurrence among young women with breast cancer.

These results highlight the need for clinicians to investigate potential high-grade lymphoid malignancies in cases of refractory CAD.

The American Association for Cancer Research has released its annual Cancer Progress Report, highlighting the recent progress in cancer research. Keith Flaherty, M.D., chair of the AACR Cancer ...

Lyrfigtu (lirafugratinib) is approved for previously treated, unresectable, or metastatic FGFR2-altered cholangiocarcinoma based on data from the ReFocus trial.

Researchers analyzed the domain coverage and clinical application of screening tools used to assess palliative care needs in oncology.

A presentation at ONS Bridge 2026 outlines the 4Ms framework for providing age-friendly care to older patients with cancer.

In this study, researchers evaluated patterns of practice-reported screening for pain and depression as well as patient-reported receipt of assistance for these conditions.